NFAT5 and cancer: There was no significant difference in induced NFAT5 expression in sensitive vs. resistant LCLs exposed to GWAS-flagged compounds (Fig 6D) and no significant correlation between NFAT5 gene expression and GWAS-flagged drug treatments in cancer cell lines using the PRISM and CTD2 databases from DepMap.